Supraventricular Tachycardia clinical trials at UCSF
1 research study open to eligible people
Supraventricular tachycardia is a rapid heartbeat starting in the upper chambers of the heart. UCSF is observing fetuses diagnosed with this condition to collect data. This study will provide insights into fetal heart rhythm disorders.
Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
open to eligible females ages 16-50
The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large clinical database to determine and compare the efficacy and safety of different prenatal treatment strategies including observation without immediate treatment, transplacental antiarrhythmic fetal treatment and direct fetal treatment from the time of tachycardia diagnosis to death, neonatal hospital discharge or to a maximum of 30 days after birth.
San Francisco, California and other locations
Last updated: